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Huntington's disease is a progressive neurodegenerative disease caused by expansion of the polyglutamine
domain in the first exon of huntingtin (HttEx1). The extent of expansion correlates with disease progression
and formation of amyloid-like protein deposits within the brain. The latter display polymorphism at the
microscopic level, both in cerebral tissue and in vitro. Such polymorphism can dramatically influence
cytotoxicity, leading to much interest in the conditions and mechanisms that dictate the formation of
polymorphs. We examine conditions that govern HttEx1 polymorphism in vitro, including concentration and
the role of the non-polyglutamine flanking domains. Using electron microscopy, we observe polymorphs that
differ in width and tendency for higher-order bundling. Strikingly, aggregation yields different polymorphs at
low and high concentrations. Narrow filaments dominate at low concentrations that may be more relevant in
vivo. We dissect the role of N- and C-terminal flanking domains using protein with the former (httNT or N17)
largely removed. The truncated protein is generated by trypsin cleavage of soluble HttEx1 fusion protein,
which we analyze in some detail. Dye binding and solid-state NMR studies reveal changes in fibril surface
characteristics and flanking domain mobility. Higher-order interactions appear facilitated by the C-terminal tail,
while the polyglutamine forms an amyloid core resembling those of other polyglutamine deposits. Fibril-
surface-mediated branching, previously attributed to secondary nucleation, is reduced in absence of httNT. A
new model for the architecture of the HttEx1 filaments is presented and discussed in context of the assembly
mechanism and biological activity.
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
Huntington's disease (HD) is one of several
heritable diseases that are characterized by the
abnormal expansion of a CAG trinucleotide repeat
that codes for a polyglutamine (polyQ) stretch
or domain in a mutant protein [1]. In HD, polyQ
expansion occurs within the first exon (HttEx1) of the
huntingtin protein (htt) (Figure 1(a) and (b)), which
results in the deposition of htt N-terminal fragments
(including HttEx1) as neuronal inclusion bodies. Theuthor(s). Published by Elsevier Ltd. This
ses/by/4.0/).misfolding and deposition of the mutant protein is
generally associated with a toxic gain-of-function
that contributes to neuronal degradation in HD [3,4].
The mature protein deposits formed in HD reflect an
amyloid-type molecular architecture, which they
have in common with protein aggregates found in
Parkinson's and Alzheimer's disease patients
[1,5–7]. Similar to the protein misfolding and amyloid
formation processes in those disorders, their HD
counterparts are considered disease relevant due to
their ability to contribute to disease toxicity, diseaseis an open access article under the CC BY license (http://
Journal of Molecular Biology (2020) 432, 4722–4744
Figure 1. Huntingtin exon 1 and the maltose-binding protein (MBP) fusion construct. Primary and secondary structure
schematics of wild-type HttEx1 (a) and mutant HttEx1 (b) showing the httNT domain (orange; α-helix), polyQ domain
(green; intrinsically disordered), and the proline-rich domain (PRD), blue; intrinsically disordered with PPII helices). Mutant
Q44-HttEx1 contains an expanded polyQ domain. (c) Top: Primary structure schematic of the employed MBP-HttEx1
fusion protein, with C-terminal His tag marked (black). Bottom: HttEx1 monomer and free MBP are released from the MBP-
HttEx1 fusion protein by proteolytic cleavage using Factor Xa (FXa) protease. (d) Model of the previously determined fibril
architecture of single-filament narrow (~6 nm wide) HttEx1 fibrils formed at 37 °C, with a single monomer highlighted in
yellow. An example of local dynamic domains is depicted in red. The His tag is not shown. (d) is adapted from Lin et al. [2].
Copyright (2017).
4723propagation and disease onset [8–11]. Simulta-
neously, there is significant evidence that some
protein deposits may reduce cellular toxicity, and
even contribute to cellular rescue mechanisms
[12–14]. As a consequence of these findings, there
is much interest in understanding the underlying
molecular processes in hopes of finding means to
control and modulate various aspects of these as-yet
incurable disorders.
Reports of varying levels of disease toxicity
observed in cellular and organismal studies of HD
may be explained by the phenomenon of amyloid
polymorphism seen in vitro for these and other
amyloidogenic proteins [1]. Polymorphism is a key
feature of amyloid-forming proteins, where the same
protein or peptide is capable of forming a range of
distinct oligomeric, fibrillar or non-fibrillar deposits in
absence of changes in the primary or chemical
structure [15]. The obtained structure is dependent
on the environmental conditions, with important factors
being pH, temperature and the presence or absence of
agitation during aggregation. Identical proteins can
aggregate into differently structured amyloid states, or
even into either amyloid or amorphous deposits,
depending on e.g. the pH [16,17]. Importantly, such
polymorphic deposits can have different levels of
neurotoxicity, although the molecular rationale for
these toxicity differences remains as yet opaque
[18–20]. Their formation is expected to result from
distinct aggregation pathways populated by transient
species, which in turn display differing levels of
neurotoxicity and variable lifetimes. Some of these
transient species may be important contributors todisease toxicity. It has been proposed that the overall
toxicity in amyloid diseases may be reduced by
modulating key aggregation pathways to limit the
formation of oligomer precursors [21,22].
The aggregation behavior of polyQ peptides,
mutant HttEx1, and mutant proteins from other
polyQ diseases share features common to amyloido-
genic proteins. They aggregate via β-sheet-rich
nuclei, which form after a lag phase that may be
populated with oligomeric species [23]. Fibril elonga-
tion rapidly follows the formation of nuclei [19,24]. The
lag phase can be bypassed or shortened in the
presence of “seeds,” which are preformed fibrils and
fibril fragments that act as nuclei for monomers and
multimers that have not yet aggregated [5]. Recent
studies implicate seeding processes in vivo in disease
propagation in various amyloid-associated neurode-
generative disorders [9,10,25,26]. HD-associated
protein depositsmay be transmitted between neurons
inHDpatients as the disease progresses [9,10]. In this
context, it is important to note that different types of
fibril polymorphs are expected (and observed) to have
different levels of seeding ability.
The aggregates formed by mutant HttEx1 and other
polyQ proteins display polymorphism, as detected by a
variety of experimental techniques. Two such tech-
niques, which also proved essential in detailing the
polymorphs of Aβ1–40 and other amyloid forming
proteins, are transmission electron microscopy (TEM)
and magic angle spinning solid-state NMR (MAS
ssNMR) [7,27–30]. TEM studies reveal a significant
level of heterogeneity in mutant HttEx1 fibrils formed
in vitro or in cells, which limits the resolution achievable
4724by structural analyses [31–33]. Different types of
HttEx1 fibrils are formed, based on their overall
morphology and fiber width, and depending on local
environmental conditions [15,20,34]. A notable feature
of mutant HttEx1 is that its polymorphic behavior is
highly influenced by dynamic domains that flank the
aggregates' amyloid core (Figure 1(d)). Interestingly,
the domains that decorate the surface of the deposits
are considered crucial for the biological properties of
the polymorphs [13]. In mutant HttEx1, the expanded
polyQ domain makes up the amyloid core of the fibrils,
featuring an architecture that is antiparallel β-sheet,
highly rigid, and dehydrated.MAS ssNMRexperiments
revealed dynamic flanking domains exposed on the
fiber surface that lack β-sheet structure: the 17 residue
N-terminal domain (httNT or N17) and a proline-rich
C-terminal domain (PRD) containing PPII helices and
flexible random coil (RC) residues [2,7,35–39]. These
domains are also of interest in mechanistic studies of
HttEx1 aggregation as they have opposing influences
on aggregation kinetics [2,23,40,41]. Outside of the
disease-associated deposition process, the httNT
domain is very important for htt function, acting as a
binding partner for membranes, chaperones, and other
proteins with roles in membrane trafficking, cell
signaling, and the regulation of gene expression and
transcription [42–45]. Additionally, the httNT domain is
the target of several post-translational modifications
that directly influence htt function [46,47]. We previous-
ly reported two temperature-dependent polymorphs of
HttEx1 fibrils containing 44 residues in the polyQ
domain (Q44-HttEx1) that canbedistinguishedbyTEM
and MAS ssNMR [2]. Intriguingly, the polyQ fingerprint
seen byMASssNMR is the same for both temperature-
dependent polymorphs, indicating that they share an
analogous polyQ core [2]. The httNT domain and PPII
helices in the PRD are immobilized with restricted
motion proximal to the polyQ domain and the PRD as
a whole presents variable dynamics and solvent
accessibility. The main differences between the fiber
polymorphs were found in the dynamics and accessi-
bility of theC-terminal PRD,which appeared tomediate
a type of supramolecular polymorphism [48] in the fiber
architecture. We presented a model of the HttEx1 fibril
architecture, reproduced in Figure 1(d), that integrates
information obtained from TEM, MAS ssNMR and
antibody binding assays. This model reflects both
similarities and specific differences with fibril models
reported by others [39,49]. However, all current models
of HttEx1 fibril architecture are limited in their molecular
detail or lack a three-dimensional perspective. A better
understanding of the structure of these protein inclu-
sions is important for modeling their mechanism of
formation and for explaining their propensity to form
polymorphs, their biological activity, and their ability to
recruit other proteins.
In the current work, we use aggregation assays,
TEM, MAS ssNMR and model building to extend our
structural and kinetic studies of the HttEx1 and itsaggregation propensity and polymorphism. Key aims
were to understand in more detail the parameters that
underpin the known polymorphism of HttEx1 fibrils
[2,19,34] and to develop a better model of their
structure. We describe new polymorphs that we had
not reported previously and find additional parameters
that correlate with fibril polymorphism. Notably, we
report a significant role for protein concentration on the
aggregation pathway,which haspotential implications
for the biological context and will be discussed in
relation to prior studies of the multi-stage HttEx1
misfolding process [23,50]. We also probe the role of
the flanking domain httNT using an N-terminally
truncated version of HttEx1. Despite a change in
aggregation kinetics some features of the fibrils are
preserved while others are significantly modified,
pinpointing the distinct role of the N- and C-terminal
flanking domains. Integrating our current and prior
data, we present an improved and more detailed
model of the HttEx1 filament structure and discuss it in
context of the mutant protein's self-assembly mech-
anisms in vitro and in vivo.Results
Concentration of MBP-Q44-HttEx1 affects width
of mature fibrils
The fibrillization temperature is a well-known source
of polymorphism for mutant HttEx1 fibrils, with reported
impacts on neurotoxicity [2,19].We previously reported
that variation in the average fibril width is a key marker
of polymorphism inmatureQ44-HttEx1 fibrils formed at
similar concentrations but different temperatures.
Depending on conditions, “narrow” fibrils (average
width 5–7 nm) (Figure 1(d)) were generated at 37 °C
and “wide” fibrils (average 15–16 nm) at 22 °C.
Significant differences in the exposure and dynamics
of the flanking domains pointed to a tight bundling of
narrowprotofilaments to form thewide fibrils [2]. Having
noticed a surprising observation that the fibril width also
seemed to depend on the initial protein concentration,
we set out to probe in more detail some experimental
parameters that influence HttEx1 polymorphism. To do
so, we again employed our protease-cleavable HttEx1
fusion protein construct (Figure 1(c)) that enables the
on-demand release of the aggregation-prone Q44-
HttEx1 [35,40]. We allowed released Q44-HttEx1 to
aggregate at 37 °C at a range of concentrations (14.3–
98.9 μM) and measured the average fibril widths by
negative stain TEM after ≥3 days. Narrow fibrils with a
relatively well-defined width of 4–6 nm are primarily
observed at 14.3 μM (Figures 2(a) and S1(a) and (b)).
At 28.6 μM (Figure 2(b)), we still observe relatively
narrow fibrils (b10 nm width) as the dominant species,
but they are more heterogeneous as reflected in a
broader width distribution in the histogram. Moreover,
Figure 2. Q44-HttEx1 fibril polymorphism is dependent on the monomer concentration. (a–c) Histograms depicting a
range of widths observed by negative stain TEM of Q44-HttEx1 fibrils, with one representative image shown per sample.
Fibrils were prepared at 37 °C following cleavage of (a) 14.3 μM (62.5:1 FP:P), (b) 28.6 μM (62.5:1 FP:P), and (c) 98.9 μM
(42.5:1 FP:P) MBP-Q44-HttEx1 by FXa. FP:P indicates the molar ratio of MBP-Q44-HttEx1 to FXa. See Figure S1 for
additional TEM images.
4725we observe a much less populated co-existing
population of fibrils (14–17 nm in width) with a
morphology reminiscent of the 15–16 nm “wide” fibrils
previously observed to form at 22 °C [2] (Figure 2(b)).
Upon increasing the concentration to 98.9 μM, we
observe twopopulationsof fibrils (Figures2(c) and1(c))
with narrow fibrils with average widths of 5–7 nm and
wide fibrils with average widths of 21–23 nm. The latter
fibrils show a substantial degree of heterogeneity in the
histogram of width measurements, while the narrower
fibril class is relatively well defined in width. We note
that measurements of fibril widths from negative stain
TEM images can vary according to differences in stain
accumulation at the exterior surface of the fibrils as well
as any penetration into the structures. This limits the
precision, especially in these heterogeneous samples
featuring fiber-fiber interactions and bundling. The
reported image analysis was done by two independent
investigators in an attempt to account for the analysis
subjectivity, which resulted in variation of themeasuredwidth in the range of 1–2 nm. Importantly this variability
in width for each fibril class is significantly smaller than
differences in width between the fibril classes that we
identified here (Figure 2) and previously [2].
We also performed a more extensive systematic
analysis of fibril morphology as a function of the
concentration and observed dramatic effects on the
microscopic morphology of the resulting mature
Q44-HttEx1 fibrils. Histograms depicting the distri-
bution of fibril widths are shown in Figure S2. At low
monomer concentrations, we see predominantly
narrow fibrils (at 7.2–28.6 μM MBP-Q44-HttEx1). A
mix of “narrow” and “wide” fibrils (width N 16 nm)
form at 78.8–98.9 μM MBP-Q44-HttEx1. However,
narrow fibrils are also produced for the higher fusion
protein concentration of 98.9 μM, when the cleavage
rate is limited due to large fusion protein to protease
(FP:P) molar ratios, resulting in low HttEx1 concen-
trations present during the initial stages of aggrega-
tion. Interestingly, at even lower concentrations of
4726free HttEx1, “intermediate” width fibrils (between 9
and 16 nm) are observed (≤14.3 μM MBP-Q44-
HttEx1 with FP:P of 510:1 or 1500:1). Thus, in
summary, we see that polymorphic assembly of
Q44-HttEx1 yields fibrils that can be classified by
their averaged width and that this polymorphic
behavior is sensitive to the HttEx1 concentration,
with wider fibrils being dominant at high HttEx1
concentration.
Kinetics of Q44-HttEx1 monomer release by
Factor Xa protease
Fibrillization is initiated in the above experiments by
an approach employed in numerous HttEx1 in vitro
studies where the Q44-HttEx1 monomers are re-
leased from a soluble fusion protein by proteolytic
cleavage (Figure 1(c)) [2,19,33,40,51–56]. As such,
the concentration of the Q44-HttEx1 monomer is
changing during initial stages of the assay, leading to
additional complexities in the kinetic analysis [51]
and potential implications for the interpretation of
concentration-dependent polymorphism. We ana-
lyzed the kinetics of monomer release using SDS-
PAGE to monitor the disappearance of fusion protein
and production of free MBP over time (Figure S3). At
14–15 μMMBP-HttEx1 and lowFP:Pmolar ratios, the
data show complete conversion to the free monomer
state within 15 min to an hour, leading to detectable
fibril formation within 24 h (Figure S3(a–d)). A
progressive delay in fibril formation is observed as
themonomer release is slowed down. At 15,000:1 FP:
P, no fusion protein cleavage or monomer release is
detectable even after 41 h (Figure S3(a)), and fibril
formation is observed after 10 days. These findings
reinforce and support prior reports indicating that the
uncleaved fusion protein is not incorporated into the
Q44-HttEx1 fibrils [2], in line with our own current and
prior in-depth ssNMR studies of the fibrils (where no
MBP signals are detected). Moreover, the effective
monomer concentrations at highly substoichiometric
P:FP ratios are lower than might be expected, at least
during the crucial initial stages of the aggregation
process.
Morphological analysis
Branching is apparent in some of the observed
fibrils (Figure 3(a), left; Figure S4) as also observed
by others [51,57]. This is significant because most
amyloid fibrils do not branch, and indeed lack of
branching is seen as a defining feature of amyloids
[51]. Here, we see that branching mostly affects the
wider Q44-HttEx1 fibrils. Another, likely related,
feature of the wider fibrils is that many of them
show striations along their long axis. These striations
are more easily visualized when we sum the gray
values along the (aligned) fibril axis, as illustrated in
Figure 3(b). We ascribe the striations to thepresence of multiple bundled protofilaments [58].
Unlike the wide fibrils, the surface of both the narrow
and intermediate fibrils frequently appears fuzzy,
likely due to their exposed disordered flanking
domains. It is possible that the narrow and interme-
diate fibrils also feature striations that are obscured
by this fuzziness. Even within a single sample the
characteristics of the Q44-HttEx1 fibrils can be
heterogeneous. Two examples of narrow fibrils
with respective average widths of 8.3 and 5.9 nm,
and an intermediate fibril with a width of 16.8 nm, are
shown in Figure 3(d). Figure 3(e) shows a fibril with
varying width across the fibril axis; the center of the
fibril is narrower than either end, which was also
seen in fibrils from most other sample conditions.
The increase in width at either fibril end in Figure 3(e)
appears in quantified steps of a few nm, as opposed
to a gradual change. These variations in widths
between fibrils and along the length of individual
fibrils provide further evidence of the presence of co-
aligned protofilaments in the individual fibrils.
Larger bundles of fibrils (Figure 3(c)) are observed
in many of the samples containing “narrow” and
“intermediate” fibrils but are not observed in any
sample with a significant population of “wide” fibrils.
In our TEM data, these fibril bundles often are
extremely dark due to high levels of staining between
and around bundled fibrils. Figure 3(c) includes an
image processed to enhance the visibility of one
such bundle (see Materials and Methods). The
widths observed for individual fibrils within a bundle
are consistent with the widths observed for the
isolated narrow and intermediate fibrils. Since these
fibril types feature more exposed flanking domains
resulting in their fuzzy appearance (see above), it
seems likely that this bundling may involve these
flanking regions (see Discussion).
Impacts of temperature on cleavage and
aggregation
We wondered if our previously found effect of
temperature on fibril polymorphism [2] may actually
relate to an effect of temperature on the cleavage
process, causing significant differences in the time-
dependent monomer concentration. However, in direct
comparisons, we find that the rate of monomer release
by the protease employed (FXa) shows negligible
differences at 22 and 37 °C (Figure S3(a, g, h), Figure
S5(a)). As an aside, in comparative measurements the
rate of monomer release is sensitive to the length of
the polyQ domain, with the cleavage of wild-type
MBP-Q20-HttEx1 being significantly faster than for
MBP-Q44-HttEx1 (Figure S3(e)). To compare to the
fibrils formedat 37 °C (above), we also allowed fibrils to
form at 22 °C, at 10–45 μMand 625:1–35:1 FP:P. The
average fibril width was consistently 15–16 nm, similar
to the intermediate fibrils formed at 37 °C described
above and in agreement with our prior work [2].
Figure 3. Morphological analysis of Q44-HttEx1 fibrils. (a) Wide (N16 nm) fibrils formed from 78.8 μMMBP-Q44-HttEx1; 170:1 FP:P. Left: fibril with two branch points
(fibril border highlighted yellow). (b) Fibril area displaying striations that correspond to a supramolecular multifilament structure. High gray values mark regions with
increased levels of staining. Top right: projected grayscale values summed along the fiber length, as a function of the fiber diameter, based on the aligned fiber section
shown below. (c) Fibril bundle composed of intermediate (N9 nm and b16 nm) width fibrils, formed from 10.1 μM MBP-Q44-HttEx1; 510:1 FP:P. A band pass filter has
been applied to the image to balance contrast. (d–e) Fibrils from a single sample of aggregated 28.6 μM MBP-Q44-HttEx1 (62.5:1 FP:P). (d) Although the majority of
fibrils observed in this sample were categorized as narrow, TEM-based width analysis shows there is heterogeneity of fibril widths within the sample. Shown are aligned
fiber sections and corresponding grayscale projections as in (b). (e) Fibril width can vary along the long axis of a single fibril.
4727
4728Thus, the concentration dependence of HttEx1 poly-
morphism described here is distinct from the
temperature-induced effects described by us and
others in prior work. Observed temperature effects on
Q44-HttEx1 polymorphism are not attributable to
differences in cleavage kinetics and monomer
concentration.
Aggregation of ΔN15-Q44-HttEx1 fibrils
The httNT flanking domain accelerates and initi-
ates the aggregation of HttEx1 [36,50,59], facilitating
also alternative HttEx1 aggregation pathways that
are not primarily driven by intermolecular interac-
tions between polyQ domains [23,50]. Given this key
role, and the fact that both flanking domains stabilize
HttEx1 supramolecular polymorphism [2], we set out
to probe the impact of eliminating the httNT domain
on Q44-HttEx1 aggregation. To do so, rather than
use FXa protease, we used an alternative trypsin
cleavage protocol exploiting a trypsin cleavage site
near the end of httNT (Figure 4(a)) [2,56]. First, we
performed a detailed analysis of the trypsin cleavage
kinetics and cleavage products (Figures S6–S7) at
22 °C, which revealed that trypsin preferentially
cleaves MBP-Q44-HttEx1 at residue R[−1] (the last
residue prior to HttEx1) to release Q44-HttEx1, but
then sequentially and efficiently cleaves the httNT
domain from the N terminus to C terminus at K6, K9,
and K15 (Figure S6). Thus, we can rapidly generate
ΔN15-Q44-HttEx1, which cannot assemble via an
httNT-driven aggregation pathway [50]. We then
monitored amyloid formation of Q44-HttEx1 and
ΔN15-Q44-HttEx1 over time at 22 °C using thioflavin
T (ThT) dye that preferentially fluoresces when bound
to amyloids (Figure 4(b)) [2,53]. For normal Q44-
HttEx1, a lag time of approximately 2 h was observed
prior to rapid polymerization that completed within
1 day (Figure 4(b, inset)). In contrast, the lag time
increased six fold and polymerization was completed
within 3 days for the ΔN15-Q44-HttEx1 fibrils (Figure 4
(b, inset)), supporting the known role of httNT in setting
the amyloid kinetics [36,50,59]. Using SDS-PAGE and
a previously described HPLC-based sedimentation
assay [2], monomer concentration was measured in
parallel to the ThT assays at 22 °C. Complete
monomer release was observed within 16 and 5 min
for Q44-HttEx1 and ΔN15-Q44-HttEx1, respectively,
(Figure 4(c)), well within the amyloid lag phases.
In order to gain insight into the possible effects the
httNT domain has on the aggregation mechanism
and the amyloid fibril kinetics, we fit the ThT results
to different aggregation kinetics models (Figure 4(b))
using AmyloFit [60]. The aggregation kinetics of both
Q44-HttEx1 and ΔN15-Q44-HttEx1 were found to be
consistent with a typical primary nucleated elonga-
tion model (solid lines), although models dominated
by secondary nucleation (dotted lines) and fragmen-
tation (dashed lines) fit the data equally well [60].Interestingly, the ThT fluorescence is ~2.5× higher
in the plateau phase compared to cleavage with FXa
protease (Figure 4(d)), even when seeding. We
interpret this to indicate a structural difference in the
trypsin-produced fibrils that changes the extent or
mode of ThT dye binding to the fibril surface (see
also Discussion) [61]. By TEM, we observe that the
ΔN15-Q44-HttEx1 fibrils predominantly have widths
between 8 and 15 nm with an average width of
11.6 nm (Figure 4(e)). A small population of fibrils
have widths exceeding 15 nm (Figure 4(f)). The
width again varies along the fiber axis in some fibrils,
however at a much lower frequency than observed
for Q44-HttEx1. Both isolated fibrils and bundled
fibrils with frayed ends are observed. Striations were
visible in a small number of fibrils (Figure 4(e) and (f),
far right). Altogether, we observed that the missing
httNT segment affects the fibril morphology and
surface features, but does not appear to disrupt fibril
bundling, providing further support for the prominent
role of the PRD in those interfilament interactions [2].
However, branching events are not observed for the
ΔN15 fibrils, potentially highlighting a role for the
httNT domain in this phenomenon.
Comparison between Q44-HttEx1 and ΔN15-
Q44-HttEx1 fibrils using MAS ssNMR
To gain more insights into the molecular conse-
quences of omitting most of the httNT domain, we
applied MAS ssNMR to the fibrils formed by uniformly
13C,15N-labeled ΔN15-Q44-HttEx1 aggregated at
22 °C. 1D 13C cross-polarization (CP) ssNMR exper-
iments were used to compare the rigid parts of Q44-
HttEx1 andΔN15-Q44-HttEx1 fibrils, both aggregated
at 22 °C (Figure 5(a)). The dominant peaks are very
similar, but specific smaller peaks are missing in the
ΔN15-Q44-HttEx1 fibrils. These peaks coincide
with those signals that we previously attributed to
the α-helical and partly immobilized httNT, providing
an indirect confirmation of these prior assignments
[2,36]. The spectral differences are visualized in
Figure 5(a, bottom), based on an overlay of the
ΔN15-Q44-HttEx1 and Q44-HttEx1 spectra. In the
aliphatic region, several peaks are missing that
correspond to the methyl groups in Met(1 and 8), Ala
(2 and 10), Thr3 and Leu(4, 7, and 14), Cε of residues
Lys(6, 9, and 15), and residue Glu5. There is also a
noticeable decrease in the area of the broad peak
observed in the backbone carbonyl (between 165 and
190 ppm) and Cα regions for ΔN15-Q44-HttEx1.
More insight is gained from 2D ssNMR spectra.
The 2D 13C–13C DARR spectrum of ΔN15-Q44-
HttEx1 (Figure 6(a) and (b)) consists overwhelmingly
of Gln and Pro cross-peaks. As expected from the
similarity of the 1D spectra, these peaks coincide
perfectly with those of the polyQ amyloid core and
the PPII-helical oligoPro segments of normal Q44-
HttEx1 fibrils. In contrast, other cross-peaks
Figure 4. Morphology of ΔN15-Q44-HttEx1 fibrils that lack most of httNT. (a) Schematic diagram of the employed cleavage reaction, in which trypsin cleavage
liberates ΔN15-Q44-HttEx1 after a rapid multistep cleavage process (Figure S6). (b) The formation of Q44-HttEx1 (red) and ΔN15-Q44-HttEx1 (blue) amyloid fibrils over
time tracked by ThT fluorescence, normalized to the maximum fluorescence of the predicted curves (nucleated elongation) for each. Data are fit to nucleated elongation
(solid), secondary nucleation dominated (dotted), and fragmentation dominated (dashed) aggregation kinetics models using AmyloFit [60]. Right: magnified inset of the
lag phase. (c) Normalized Q44-HttEx1 (red) and ΔN15-Q44-HttEx1 (blue) monomer concentrations over time following cleavage by FXa and trypsin, respectively,
measured by SDS-PAGE and HPLC [2]. The HPLC assays were performed in parallel to the ThT fluorescence assays. (d) Average ThT fluorescence in the lag and
plateau phase for Q44-HttEx1 (red) and ΔN15-Q44-HttEx1 (blue). The average fluorescence of a control sample containing MBP-Q44-HttEx1 only was subtracted for
each. The lag phase was measured at 50 and 60 min for ΔN15-Q44-HttEx1 (n = 3) and Q44-HttEx1 (n = 2), respectively. The plateau phase was measured at 4 and
3 days for ΔN15-Q44-HttEx1 (n = 3) and Q44-HttEx1 (n = 2) respectively. (e) Distribution of widths measured for ΔN15-Q44-HttEx1 fibrils, outfitted with uniform
13C,15N labels for ssNMR. The average width is between 11 and 12 nm (right); however, a wide distribution of widths was observed (left). (f) Wide ΔN15-Q44-HttEx1
fibrils (~18–19 nm). Right: evidence of striations consistent with a supramolecular multifilament structure.
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Figure 5. MAS SSNMR comparison of ΔN15-Q44-HttEx1 and Q44-HttEx1 fibrils. (a) Top: 1D cross polarization (CP) 13C spectrum of Q44-HttEx1 [2] and (middle)
ΔN15-Q44-HttEx1, and (bottom) their overlaid comparison, normalized to the peak maxima for Q44-HttEx1. Spectral differences are consistent with the absence in the
latter sample of the partly immobilized httNT seen in HttEx1 fibrils. (b) From top to bottom: 13C INEPT of Q44-HttEx1, ΔN15-Q44-HttEx1, and overlaid. The CP spectra
feature signals from rigid and partly immobilized parts of the structure, while the INEPT data show only highly flexible residues. The spectra of Q44-HttEx1 are reprinted
with permission from Lin et al. [2].
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Figure 6. 2D ssNMR analysis of ΔN15-Q44-HttEx1 and Q44-HttEx1 fibrils. (a, b) Overlay of 2D CP/DARR ssNMR spectra for U-13C,15N ΔN15-Q44-HttEx1 (blue)
and Q44-HttEx1 (red) [2], obtained at 13 kHz MAS and 8 ms DARR mixing. In these CP spectra, the signals from immobilized parts of the protein assembly are visible.
(b) shows assignment of preserved peaks, while (a) shows assignments for peaks absent in ΔN15-HttEx1 fibrils. (c, d) Analogous 13C–13C INEPT-TOBSY ssNMR
spectra of the same samples, reflecting signals of flexible residues. (e) 1D slices from a series of 2D TEDOR spectra with marked mixing times, for Gln N-Cα and Pro N-
Cα peaks. Differences in maximum transfer times indicate mobility differences between Gln, ProPPII and ProRC. (f) Normalized CP/PDSD buildup profiles for proline
residues with random coil (RC; = circles) and PPII-helical (= diamonds) structure in PRD of Q44-HttEx1 [2], and (g) ΔN15-Q44-HttEx1 fibrils. Lower buildup curves are
indicative of increased mobility, showing that the random-coil prolines are more dynamic than the PPII helices and that the PRD in ΔN15-Q44-HttEx1 fibrils retains
higher mobility than in Q44-HttEx1 fibrils. Q44-HttEx1 spectra are reprinted with permission from Lin et al. [2]. 4731
4732previously assigned in the Q44-HttEx1 fibrils are
absent. Most notably, these include signals from httNT
residues, as expected. However, specific peaks from
the C-terminal flanking domain are also absent. These
include two peaks representing Val103 along with
additional alanine peaks and immobilized parts of the
PRD inQ44-HttEx1 [2]. Thus, in absence of httNT these
polyQ-proximal partly immobilized parts of the PRD
become more mobile. Peaks representing proline
residues with a random coil secondary structure
(ProRC) are missing completely in the short-mixing
DARR spectrum. They do occur in a proton-driven spin
diffusion (PDSD) experiment with 250 ms of 13C–13C
mixing (Figure S8(a)) designed to recouple longer-
range or dynamically reduced dipolar couplings. Peaks
of low intensity assigned to random coil alainines
(AlaRC) are observed in the PDSD spectrum; however,
peaks assigned to Val103 are not. We also performed
2D heteronuclear 13C–15N correlation spectra, shown
in Figure S8(b). The NCACX and NCOCX spectra
show rigid polyQ correlations that closely match the
data seen previously for HttEx1 and other polyQ
amyloid aggregates [40,62,64]. No peaks from other
amino acids are detected by NCACX or NCOCX. The
lack of Pro peaks in these spectra is due to a
combination of the lack of directly bonded N-1H in the
Pro backbone, along with dynamics of the PRD (see
below). As aworkaround,weemployed the2DTEDOR
experiment that is not dependent on 1H to 15N CP
transfers, and thus works well for Pro residues (Figure
S8(b); bottom). Indeed, in this spectrum, the Pro peaks
are observed at a 15N frequency of 136 ppm, although
the peaks require a longer TEDOR buildup time than
expected for rigid residues (Figure 6(e)). In summary,
these ssNMR data reveal little to no difference in the
rigid polyQ core of ΔN15-Q44-HttEx1 compared to
Q44-HttEx1 [2,40], but indicate dynamic changes in the
immobilized oligoproline parts of thePRD, and a lack of
httNT signals.
Dynamics of the C-terminal flanking domain of
ΔN15-Q44-HttEx1 fibrils
Polarization buildup curves from CP/PDSD spectra
provided evidence of dynamic differences in the Q44-
HttEx1 polymorphs [2]. We performed both 13C–13C
PDSD and 13C–15N TEDOR variable-mixing time
experiments [63] in order to analyze the mobility in
ΔN15-Q44-HttEx1 fibrils (Figure 6(f) and (g)) [2].
Polarization transfer between directly bonded Cα-Cβ
carbons is rapid in a rigid lattice, with maximum
PDSD polarization transfer (10–20%) reached within
10–20 ms [2]. As before, such a fast buildup is
observed for Cα-Cβ glutamine peaks within the
amyloid core [2], indicating their crystal-like rigidity.
However, the one-bond polarization buildup curves
for PPII and ProRC residues in the PRD ofΔN15-Q44-
HttEx1 experience a much slower buildup and lower
peak maxima, indicating that segments of the PRDexperience less rigidity than in HttEx1 (Figure 6(f) and
(g)) [2]. A more dramatic difference was observed for
two-bond Cα-Cγ polarization transfers, signifying that
the ProRC residues experience more dynamics than
those with a PPII structure. Analogous findings are
obtained in the TEDOR 13C–15N recoupling experi-
ments [63], where the N–Cα one-bond cross-peaks of
the polyQ core and PRD are significantly different in
their build-up timing (Figure 6(e)). Combined, the
MAS ssNMR results show that the PRD flanking
domain of ΔN15-Q44-HttEx1 is more mobile than the
polyQ core, even more so than their counterparts in
Q44-HttEx1 fibrils.
Previously, we and others have noted the presence
of a substantial segment of highly flexible residues in
the C-terminal tail of aggregated HttEx1 [2,34,64].
These residues are detected using ssNMR experi-
ments based on the INEPT scheme, which captures
signals from residues with similar mobility to rapidly
tumbling soluble protein [65]. In ΔN15-Q44-HttEx1, we
again observe these signalswith no notable changes in
the positions of detected peaks, suggesting that the
structural ensemble of these flexible residues is
unchanged (Figure 5(b)). The peak intensities are
relatively similar, although there is a decrease in the
peaks in the aromatic region (80–165 ppm), possibly
due to a loss of one of the Phe residues within the
missing httNT segment. 2D 13C–13C INEPT-based
total through bond correlation spectroscopy (TOBSY)
spectra showed more peaks for Q44-HttEx1 (Figure 6
(c)) than in ΔN15-Q44-HttEx1 (Figure 6(d)) [2]. The
peaksmissing inΔN15-Q44-HttEx1 are consistent with
residues found in the httNT domain, along with signals
assigned as Arg (which is not found in httNT). A small
signal is observed that we previously assigned to Met1
for Q44-HttEx1 [2], likely due to incomplete trypsin
cleavage. In summary, these INEPT-based analyses
show no evidence of a large change in the dynamics of
the most flexible parts of the PRD flanking domains.
Interestingly, they reveal (retrospectively) the presence
of flexible residues in the httNT of the HttEx1 fibrils,
coexisting with immobilized α-helical httNT (reaffirmed
by the spectral differences in the CP spectra above).
From these results, we infer a subpopulation of proteins
with a more disordered httNT, reminiscent of the
findings reported by others on HttEx1 polymorphs
that lack signals from the immobilized httNT [49,64].
Amolecularmodel of the HttEx1 fibril architecture
The width of the observed single-filament Q44-
HttEx1 fibrils appears to be approximately uniform.
Since we would expect the narrow fibrils to be
randomly oriented on the plane of the TEM grids,
and with no indication of significant differences in
width, it appears that the width and height of these
filaments must be similar (Figure 7(a, left)). Our
current and prior data support the conclusion that wider
fibril polymorphs are assembled from multiple narrow
4733filaments adhered longitudinally, with the individual
filaments mimicking the dimensions of the narrow
fibrils, representing a type of supramolecular polymor-
phism (Figure 7(a, right)) [48]. With our new data in
hand, we decided to revisit our structural model for the
misfolded HttEx1 fibrils to render our prior schematic
model [2] more realistic. It was previously shown by
ssNMR that the polyQ core of the Q44-HttEx1 fibrils
(and other polyQ aggregates) features unusually long
β-strands [40,62,64], in contrast to various recent
structures of other disease-relevant amyloid fibrils
[6,66–68]. This point is also illustrated in Figure S9 in
the SI, which shows two such amyloid core architec-
tures featuring compact architectures of short β-strand
elements separated by β-arc bends or turns (“CASSA”
motif [6]). In such amyloid structures, neighboring
amino acids often have different Ramachandran
dihedral angles (Figure S9e). This would result in
characteristic peak patterns in NCOCXssNMRspectra
(Figure S9c–h), as those spectra are based on
polarization exchange between neighboring residues.
Clearly, experimental polyQ NCOCX spectra are not
consistent with an architecture with many short β-
strands, and can only be explained by long and largely
uninterrupted β-strands. In our detailed analysis of
Q44-HttEx1 fibrils, we previously concluded that the
protofilament core featured β-strands of approximately
6.5 nm long, matching the TEM-observed width of the
narrow fibril type [40]. Rather than CASSA motifs, the
polyQ core is likely featuring a slab- or block-like
architecture previously reported in other studies
[69,70]. Although not shown in our model, or easily
seen in our TEMdata, thesepolyQ-based fibrilsmaybe
twisted like other amyloids [71,72].
Our modeling of the Q44-HttEx1 fiber architecture
will thus assume such a core architecture, in which
the length of the β-strands closely approximates the
filament width as seen in negative stain TEM [2].
Orthogonal to the β-strand long axis, the fiber
diameter appears to be similar and thus must be
assembled from multiple β-sheets. In order to
estimate the number of β-sheets within one proto-
filament, we can refer to the inter-β-sheet distances
of 8.2 Å for HttEx1 fibrils, determined here by X-ray
powder diffraction (Figure S10(a)) in agreement with
previous work [2,73]. To integrate the TEM, X-ray
and ssNMR constraints, we built a structural model
of a single filament using UCSF Chimera (Figures 7
(b) and S10(c)) assuming a length and depth of the
amyloid core of ~6.5 nm and torsion angle con-
straints (Figure S10(b)) that we previously deter-
mined [40,74]. This model predicts a maximum of
nine sheets per filament, and features the interdig-
itating side chains identified in our prior MAS ssNMR
studies [40]. The core is further stabilized by intra-
sheet side-chain and backbone hydrogen bonds
along with potential inter-sheet side-chain to back-
bone hydrogen bonds (Figure S10(c)). This model
would imply that most of the Gln residues are buriedand distant from the solvent molecules. This
observation is not only consistent with prior X-ray
studies of polyQ peptides, but also with ssNMR
relaxation and water-interaction measurements on
HttEx1 and other polyQ aggregates [40,62,69,75]. In
summary, we constructed an improved model of the
Q44-HttEx1 fibril base filaments, which provides a
new perspective on their molecular architecture, with
implications that will be examined below.Discussion
Hierarchical supramolecular polymorphism of
HttEx1 fibrils
Supramolecular polymorphism has now been iden-
tified not only in the HD protein deposits, but also in
amyloid structures formed in AD and other neurode-
generative diseases [2,48,76,77]. We experimentally
probed key parameters affecting this phenomenon in
mutant HttEx1 aggregation. Across a range of
different sample conditions, we observed various
indicators that HttEx1 fibrils contain hierarchical
side-by-side assemblies of individual filaments,
reflecting multiple levels of supramolecular assembly.
The presence of protofilaments is seen by TEM as
visible striations, fraying of fiber ends, branching
events, and variations in width along the length of
fibrils. Strikingly, the data point to a common width of
4–7 nm for the individual filaments, consistent with the
Q44-HttEx1 protofilament architecture that we previ-
ously reported [2]. We observed a propensity for
higher-order bundling of the narrow and intermediate
fibrils, reminiscent of previous in vitro studies, and of
HttEx1 inclusions in cells [32]. An intriguing observa-
tion is that the wide fibrils lacked the propensity for
such higher order bundling. It is tempting to relate this
to the disposition of disordered flanking segments on
the surface of the filaments. These segments likely
explain the fuzzy appearance of the narrow and
intermediate fibrils (that are prone to bundling), but
which is less apparent in the wider fibrils. In our prior
work, we probed for solvent accessibility of the
flanking domains in two temperature dependent
polymorphs of Q44-HttEx1 using a combination of
MAS ssNMR and antibody binding assays [2]. We
established that the httNT and PRD are partly buried
and immobilized in the wider fibrils that had been
formed at 22 °C compared to the narrower fibrils
formed at 37 °C. In those studies, interactions among
the flanking domainswere proposed to be responsible
for stabilizing the wider fibrils' structure, with a
particular role for the C-terminal PRD segment. The
current data reinforce this conclusion. Even the
removal of most of the httNT segment did not abolish
the higher order assemblies, showing that httNT is not
directly involved.
Figure 7. Model building ofQ44-HttEx1 fibril structure and assembly. (a) Hypotheticalmodel of a single-filament “narrow” fibril and amulti-filament “wide” fibril. (b) Based on TEM
widths, each filament core contains several β-sheets with the depth of the sheet stack approximately the same as the β-strand length. Shown is amodel of β-sheet stacking within a
filament (seealsoSupplementaryFigureS10),with eachsheet representedasauniquecolor, showinghowapproximately ninestackedβ-sheetsmakeupa6- to 7-nm filament core.
(c) Secondary nucleation events on the filament surface initiate the formation of protofilaments that can elongate in parallel (middle) or branch sideways while remaining associated
with the template filament (right). Color coding in panels (a, c) is: green: polyQ β-strand core; blue: PRD, with blue cylinders being PPII helices; orange cylinder: httNT segment.
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4735Protein concentration as a polymorphism con-
trolling parameter
Previous studies concluded that HttEx1 displays a
temperature-dependent fibril polymorphism. Our cur-
rent experiments identify protein concentration as
another important determinant of fibril architecture. In
particular, higher concentrations of Q44-HttEx1
monomer are necessary to induce the formation of
the wide fibrils at 37 °C, while lower concentrations
result in distinct polymorphs, including narrower ones
with more exposed flanking regions. It is worth noting
that under disease conditions, the concentrations of
HttEx1 are likely to be at or below the low end of the
range studied here [78]. Thus, it is possible that the
neuronal conditions favor the formation of narrower
single-filament fibrils. Given that the flanking regions
are well known to interact with protein partners and
cellular membranes, their increased exposure on
such fibrilsmaywell be biologically relevant. Naturally,
these same interactions may further influence the
aggregation behavior and polymorphism, beyond
what is seen here in vitro. It is important to note that
the fibril width (in the nm range) is not directly related to
the size of the μm-sized puncta or inclusions typically
observed by fluorescence microscopy. This important
point was recently visualized in cryo-electron tomog-
raphy and super resolution studies [32,79,80].
A possible rationale for the observed concentration
dependence is that prior work has identified at least two
parallel competing aggregation mechanisms with
different dependences on the monomer concentration
[50,52]. At high concentrations, direct interactions
among the expanded polyQ domains were reported
to drive the aggregation process, with the flanking
domains playing a secondary role. At lower concen-
trations, the httNT domains drive aggregation by first
undergoing non-amyloidogenic self-assembly, causing
locally high concentrations that then trigger amyloido-
genic interactions among the polyQ segments. Con-
sistentwith this secondmechanisticmodel,weobserve
that the ΔN15-Q44-HttEx1 monomers aggregate at a
slower rate than Q44-HttEx1.
Role of httNT in HttEx1's aggregationmechanisms
In many ways, the ΔN15-Q44-HttEx1 fibrils are
morphologically similar to normal HttEx1. They also
appear capable of higher-order fiber bundling,
showing that httNT is not required for these types of
interfilament interactions. Yet, there are a number of
interesting differences. A clear difference in ThT
fluorescence (for the same amount of protein)
indicates a change in the binding of this amyloid-
binding dye to the two kinds of fibril, with potential
implications for our understanding of polymorph-
specific dyes and contrast agents [61]. MAS ssNMR
detected no changes in the polyQ amyloid core
structure relative to that of normal HttEx1 fibrils[2,40,64], despite this technique being highly sensi-
tive to such structural changes. Thus, differences in
the (weight-normalized) ThT signal must stem from
changes in the disposition or accessibility of the
polyQ-based amyloid core surface, with an in-
creased number of accessible binding sites present
for the same fibril mass. The ΔN15-Q44-HttEx1
fibrils have an average width of 11.6 nm, unlike any
of the fibril types observed for Q44-HttEx1, exceed-
ing the width of the “narrow” fibrils that form at low
HttEx1 concentrations. Relative to our model of the
Q44-HttEx1 fibril architecture (Figure 7), the average
width of fibrillar ΔN15-Q44-HttEx1 is approximately
4 nm less than the average width of the 22 °C Q44-
HttEx1 fibrils. It remains unclear whether this is due
to a closer inter-protofilament distance enabled by
the lack of httNT domain, or a change in the filament
architecture or the number of β-sheets within a
filament. Nonetheless, both Q44-HttEx1 and ΔN15-
Q44-HttEx1 fibrils formed with kinetics that were
consistent with a nucleated elongation model,
including secondary nucleation and fragmentation
events (Figure 4(b)). One notable difference was that
there is an absence of apparent branching in the
ΔN15-Q44-HttEx1 fibrils even though we do see
side-by-side bundling. A recent study has argued
that branching by HttEx1 is due to secondary
nucleation on the surface of existing fibrils [51].
Thus, our observations may indicate a role for the
httNT segment in such a secondary nucleation
process. If so, the interactions that still stabilize
side-by-side bundling of (ΔN15-Q44-HttEx1) fila-
ments and protofilaments must be distinct from the
interactions that mediate this nucleation and branch-
ing process.
Structural architecture of HttEx1 deposits and
associated biological implications
We observe that protein monomer concentration
plays a key role in dictating the fibril morphology. An
interesting question relates to the molecular under-
pinnings of the observed morphological features.
MAS ssNMR chemical shifts are highly sensitive to
structural differences, but no MAS ssNMR study has
yet identified any significant change in the polyQ
signature motif [2,36,40,49,62,64,81], contradicting
suggestions of qualitative differences in polyQ
architecture proposed from other structural tech-
niques [19,82]. In our data, the main differences
between polymorphs occur on the fibril surfaces, in
terms of the exposure of non-polyQ flanking do-
mains and the ThT-accessible amyloid core surface.
In Figure 7, we presented our new model for the
HttEx1 fibril structure, which explains not only the
ssNMR-detected exposure and burial of respective
HttEx1 domains, but also fits the TEM-observed
protofilament dimensions. A key feature of our
structural model is that the HttEx1 fibril surface
4736combines regions of exposed polyQ amyloid core with
regions covered with partly disordered non-amyloid
flanking domains. Both aspects of the fibril surface
have potentially important implications for the aggre-
gates' biological properties. Amyloid fibril surfaces are
increasingly thought to provide a molecular context
that enhances the conversion of (soluble) monomers
to amyloidogenic nuclei through secondary nucleation
events (Figure 7(c, left)) [5]. In HD and other amyloid
diseases, there is also an increasing realization that
the domains that form a “fuzzy” coat around an
amyloid fibril core may be of particular disease
relevance by contributing to toxic effects exerted by
cytotoxic aggregates [2,35,36,42–44]. The httNT seg-
ment is thought to interact with cellular membranes
and chaperones [45], and houses the potential
ubiquitination sites of HttEx1 [83]. The C-terminal
flanking domains are similarly implicated in interac-
tions with membranes and other cellular proteins
[13,84,85]. Recognition of exposed flanking domains
may enable the targeting of deposited HttEx1 (e.g. for
degradation), but their interactions may also have a
detrimental effect by recruiting and trapping essential
cellular components. In the HttEx1 polymorphs, these
domains (especially the PRD) mediate the supramo-
lecular self-assembly into side-by-side multifilament
fibrils and higher order bundles. Thus, the exposed
flanking domains may be in competition with cellular
components and with each other in forming dense
filament clusters. This may underpin the reported
lower levels of toxicity for large HttEx1 aggregates
detected by (confocal) microscopy [86].
Mechanistic underpinnings of fibril surface
variability and supramolecular polymorphism
How may these structural variations originate
during fibril assembly? The structure of the aggre-
gation end products is dictated by the misfolding
and aggregation pathway that led to their formation.
As such, we conclude that the dominant aggregation
pathway of HttEx1 must be concentration depen-
dent. This finding is reminiscent of prior work that
pointed to a toggling between polyQ- and httNT-
driven pathways, which was concentration depen-
dent [50]. At low concentrations, the aggregation
initiating effect of httNT was dominant, while at
higher concentrations aggregation was driven by
the expanded polyQ domain. The httNT-driven and
polyQ-driven aggregation mechanisms likely facili-
tate different core and flanking domain organization
[50]. As illustrated schematically in Figure S11, the
fibrils may end up with different degrees of symmetry
or clustering in the distribution of flanking domains.
For example, the ΔN15-Q44-HttEx1 fibrils may have
a more symmetric distribution (Figure S11(b)), due to
the lack of httNT-driven aggregation. The flanking
domain distribution would likely modulate how
surface-nucleated filaments grow (Figure S11(a)),change the interfilament distances, and affect the
propensity for multifilament fibrils to form. The
cellular environment is likely to contribute additional
complicating factors that can impose a bias on
the relative alignment of the flanking domains or
otherwise change the architecture of the resulting
aggregates. Membrane interactions involving either
of the flanking domains have been reported, which
would likely change their role in the aggregation
process [85,87,88]. Similarly, one can expect effects
from chaperones that bind the flanking domains and
various post-translational modifications [44,47,89].
The exact molecular consequences of these intra-
cellular interactions are as yet incompletely under-
stood and warrant further study.
Potential implications for mutant huntingtin at
low concentration in vivo
The concentration-dependent formation of aggre-
gates with different morphologies, dynamics and
surface characteristics may have important implica-
tions for our understanding of the fate of mutant
huntingtin in a cellular context. Based on currently
available data, the concentration of mutant Htt (and
its fragments) in vivo is measured to be much lower
than the values in typical use in mechanistic studies
using purified proteins [78]. It is interesting to note
the distinct behavior seen at very low effective
monomer concentrations produced by the very slow
release of monomer at highly substoichiometric FXa
concentrations (Figure S2(i, l)). We might have
expected narrow fibrils composed of one filament
each, but instead observe intermediate-width fibrils
with an otherwise similar appearance to those
formed at 22 °C [2]. Thus, it may be that very slow
aggregation or extremely low monomer concentra-
tions trigger yet another dominant aggregation
pathway. Understanding the structural and mecha-
nistic aspects of HttEx1 misfolding and aggregation
under ultralow HttEx1 concentrations may be an
important direction for future studies.Conclusion
Together, our results indicate that HttEx1 polymor-
phism is driven not only by temperature, but also by
other parameters including the concentration of
monomer in solution. Our findings provide further
support for the conclusion that the polymorphism of
HttEx1 (with and without the crucial httNT segment)
produces filaments with a common polyQ amyloid
core, which arrange into different supramolecular
arrangements depending on their misfolding pathway.
Interestingly, despite initiating and accelerating
HttEx1aggregation, the httNT domain is not necessary
for the interfilament interactions but does appear to be
important for initiating fibril branching. Naturally,
4737cellular conditions feature numerous complicating
factors, including aggregation-modulating (sub)cellu-
lar membranes, chaperones and htt post-translational
modifications [85,89–91]. These factors may further
modulate the misfolding process and warrant further
investigation.Materials and Methods
Protein expression and purification
The MBP-fusion protein MBP-Q44-HttEx1, featur-
ing mutant HttEx1 with 44 consecutive glutamine
residues within the polyQ domain, was subcloned
into a pMALc2x plasmid by Genscript (Piscataway,
NJ) as previously described [2,92]. Overexpression
in Escherichia coli BL21(DE3)pLysS cells (Invitro-
gen, Grand Island, NY) was done at natural isotopic
abundance for most samples, using a protocol
optimized for isotopic labeling [2]. Samples intended
for MAS ssNMRwere uniformly 13C,15N labeled with
13C D-glucose and 15N ammonium chloride (SKU
CLM-139-10 and NLM-467-10, Cambridge Isotopes,
Andover, MA) during overexpression. Cells were
harvested by pelleting at 7000g and resuspended in
PBS buffer (SKU BP399-4, Fisher BioReagents,
Pittsburgh, PA). 1 mM phenylmethanesulfonyl fluo-
ride (PMSF) (SKU 215740050, Acros Organics, New
Jersey, USA) was added to the resuspended cells
just prior to lysis and replenished every 0.5 h as
necessary. The cells were lysed by microfluidization
using an M-110Y high-pressure pneumatic high
shear fluid processor (Microfluidics, Newton, MA)
until the transparency of the lysate ceased changing
as determined visually. Debris was removed by
centrifugation at 38,720g for 1 h using a Sorvall RC
3C Plus centrifuge (Thermo Scientific, Waltham,
MA) and subsequently by filtering over Nalgene
Rapid-Flow (Thermo Scientific, Waltham, MA) and/
or Millex-GP syringe-driven (Millipore Sigma, Bur-
lington, MD) 0.22-μm PES membranes. The soluble
fusion protein was purified using a HisTrap HP nickel
column (GE Healthcare, Uppsala, Sweden) with an
imidazole (SKU I5513-100G, Sigma, St. Louis, MO)
gradient. The purified protein was exchanged into an
imidazole-free PBS buffer over an Amicon Ultra
centrifugal filter (MilliporeSigma, Burlington, MA)
with a regenerated cellulose membrane (10,000
MWCO). The concentration of the fusion protein was
determined by its average absorbance (n = 3) at
280 nm, which was measured in a 100-μl quartz
cuvette with a 1 cm path length by a DU 800 UV–
visible spectrophotometer (Beckman Coulter, Brea,
CA). The extinction coefficient of the fusion protein is
estimated to be 66,350 M−1 cm−1 (determined using
the ProtParam tool by ExPASy [93]). The protein
purity, molecular weight, and isotopic labeling yieldwere verified by ESI-TOF MS and SDS-PAGE, as
described below [35].
Fibril formation
MBP-Q44-HttEx1 was cleaved to release Q44-
HttEx1 by treating with Factor Xa (FXa) protease
(SKU PR-V5581, Promega, Madison, WI), or
cleaved to release ΔN15-Q44-HttEx1 by treating
with N-tosyl-L-phenylalanine chloromethyl ketone
treated trypsin lyophilized powder from bovine
pancreas (SKU T1426 from Sigma-Aldrich, St.
Louis, MO) re-dissolved in PBS buffer with 3 μM
HCl. The progression of protein cleavage was
monitored by SDS-PAGE (Bio-Rad Mini-Protein
Precast TGX Gels 12%) [2] or by ESI-TOF MS as
described below. For TEM studies, 10.1–98.9 μM
MBP-Q44-HttEx1 was treated with FXa at fusion
protein to protease molar ratios of 1500:1–4.25:1 FP:
P as indicated in Figures 2 and S2, and the mixture
was incubated at 37 °C for at least 1 day to allow for
Q44-HttEx1 aggregation. For ΔN15-Q44-HttEx1,
11.6 μM MBP-Q44-HttEx1 was cleaved by trypsin
at 3:1 FP:P and incubated for at least 3 days during
aggregation. Unless otherwise indicated, in all
ΔN15-Q44-HttEx1 preparations, the trypsin cleav-
age reaction was quenched after 10 min with the
addition of 26 nM PMSF.
Transmission electron microscopy
Fibrils were pelleted at 2880g for 20–30 min and
washed with PBS buffer three times to remove free
MBP and un-aggregated monomers and oligomers.
Aliquots of fibril suspensions were diluted into PBS
buffer and 5 μl of the diluted suspension were
deposited and adsorbed onto freshly glow-
discharged 400-mesh carbon-coated copper grids
(SKU FCF400CU50, Electron Microscopy Sciences,
Hatfield, PA) for 0.5–2 min. Excess buffer was
removed by blotting. The negative staining agent
used was 1% (w/v) uranyl acetate (UA) (SKU 22400,
Electron Microscopy Sciences, Hatfield, PA). Stain
was applied to the grids for approximately 5 s before
blotting, and then grids were air dried for 5 min.
Images of the negatively stained samples were
obtained on a Tecnai T12 TEM (FEI, Hillsboro, OR)
operating at 120 kV and equipped with an UltraScan
1000 CCD camera (Gatan, Pleasanton, CA). Fibril
widths were measured transverse to each fiber axis
using the straight Free-Hand tool of ImageJ [94].
Three measurements were obtained per fibril,
except in fibrils where the width varied significantly,
in which case three measurements were obtained at
the widest and narrowest points of the fibril as well as
in an intermediate area, and the average of each
was included in the analysis. In select cases, fibril
widths were verified on isolated and vertically
aligned fibrils using the Plot Profile tool of ImageJ,
4738which plots the average grayscale intensity values
across a rectangular region of an image [94], and the
width of the resulting peak was measured at its
estimated half-height. Fourier transform band pass
filters were applied to images of fibril bundles without
saturation, with 5% tolerance of direction, and
without stripe suppression or autoscaling using
ImageJ in order to aid in the visibility of individual
fibrils within the bundles, as indicated in Figure 3(b)
[94].
Cleavage kinetics assays by SDS-PAGE and
ESI-TOF MS
The kinetics of monomer release by FXa or trypsin
cleavage on MBP-Q44-HttEx1 was monitored by
SDS-PAGE for samples indicated in Figures S3, S6,
and S7. Following the addition of protease to MBP-
Q44-HttEx1 as described above, aliquots (15 μl) were
removed from the reaction mixture at the indicated
time points and mixed with an equal volume of SDS-
PAGE loading dye to terminate the proteolysis
reaction. An SDS-PAGE gel (Bio-Rad Mini-Protein
Precast TGX Gels 12%) stained with Coomassie R-
250 dye was analyzed by the Gel analyzer tool in
ImageJ [94] in order to estimate the ng of uncleaved
MBP-Q44-HttEx1 material present at each time point.
Michaelis–Menten kinetics were calculated from the
initial cleavage rates using Graphpad Prism version 7
forMac (GraphpadSoftware, La Jolla, CA). Kinetics of
cleavage were also measured in samples with
1 molar ratios of MBP-Q44-HttEx1 to either FXa or
trypsin protease, as indicated in Figures S3, S6, and
S7. In these samples, aliquots of a few μl were
removed from the reaction mixture and added to
formic acid (SKU A117-50, Fisher Chemical, Pitts-
burgh, PA) to quench the proteolysis reaction at 30 s,
1 min, 5 min, and 6 h time points. ESI-TOF MS was
used to analyze the kinetics of cleavage and identify
cleavage products, as described below.
ThT fluorescence assay
ThT fluorescence assays were performed as
described previously [2]. Briefly, FXa or trypsin was
added to 11.6 μM MBP-Q44-HttEx1 at 5:1 and 3:1
FP:P, respectively. The samples were mixed with a
vortex for 15 s and then allowed to aggregate at
22 °C for several days. At various time points, the
aggregates were resuspended using a vortex and
40 μl aliquots of the suspensions were immediately
diluted into ThT (SKU 156877, MP Biomedicals LLC,
Solon, OH) stock solution (250 μM ThT, 0.02% w/v
NaN3, 1× PBS) for a total volume of 400 μl and
protein concentration of 1.27 nM. Samples were
excited at 445 nm using a 2-nm excitation slit on a
FluoroMax-4 spectrofluorometer (Horiba; Kyoto,
Japan). Emission was recorded at 489 nm through
a 4-nm emission slit. Two measurements wereobtained for each sample per time point. Curves
were fit to nucleated elongation, secondary nucle-
ation dominated, and fragmentation dominated
models using AmyloFit over 50 basin hops [60].
HPLC-based sedimentation assay
As described previously [2], an HPLC-based
sedimentation assay was used in parallel to the
ThT assays in order to accurately monitor monomer
concentrations over time. Briefly, aggregates were
removed from 15 μl aliquots of the aggregation
mixture by centrifugation at 20,800g for 15 min.
The supernatant (5 μl) was subsequently diluted 2×
into formic acid and loaded onto an Agilent Zorbax
SB-C8 4.6 × 50 mm HPLC column with a 1.8-μm
particle size using an analytical HPLC (Agilent
Technologies). The monomer was eluted over a
15–35% C2H3N/H2O gradient (0.05% TFA, 37 °C).
The elution was monitored by absorbance at 215 nm
(A215), and monomer concentrations were deter-
mined by integrating the A215 peaks using Chem-
Station (Agilent Technologies).
Potential trypsin cleavage products of MBP-Q44-
HttEx1
ExPASy's PeptideCutter tool [93] was used to
determine 42 possible trypsin cleavage sites within
MBP-Q44-HttEx1, excluding three sites (K[−142]P
[−141], R[−101]P[−100], and K[104]P[105]) with
19.3%, 29.3% and 23.8% probabilities of cleavage.
These residue numbers are relative to the number-
ing for Q44-HttEx1 following FXa cleavage of MBP-
Q44-HttEx1. The 42 potential cleavage sites were
marked onto the predicted structure of MBP based
on the structure of fusion protein MBP-L30 (PBD ID:
1NMU) using UCSF Chimera (Figure S7) [95]. The
molecular weights of all fragments were calculated
using ExPASy's ProtParam tool [93] assuming 42
active cleavage sites. The molecular weights of all
possible fragments were calculated by combining
the molecular weights of individual fragments and
adding 18 Da (the molecular weight of water) for
each peptide bond formation. A total of 945 possible
cleavage products were identified, 760 of which
have molecular weights above 5000 Da.
Mass spectrometry
The mass of the MBP-Q44-HttEx1 fusion protein
(56.685 kDa) was confirmed within ±1 Da by ESI-
TOF MS using a MaXis II ESI-QTOF mass spec-
trometer (Bruker Daltonics, Billerica, MA). Mass
spectra were deconvoluted by maximum entropy
using Compass Data Analysis Hystar 4.1 software
(Bruker Daltonics, Billerica, MA), with lower and
upper limits of 5000 and 100,000 m/z. MBP-Q44-
HttEx1 was deemed usable for experiments if the
4739MS deconvolution curve indicated high purity without
any indication of prior proteolytic cleavage. To
identify the trypsin cleavage products of MBP-Q44-
HttEx1, the fusion protein was cleaved with trypsin in
seven independent trials and the mass spectra were
obtained from 5 μl aliquots of the reaction mixture
quenched with formic acid within the first 6 h
following the addition of trypsin. PMSF was not
added to any of the reaction mixtures. All peaks
observed in the resulting deconvoluted mass spectra
were screened against the expected molecular
weights of 760 possible cleavage products with
MW N 5000 DA within ±2 Da. An additional four
independent trials were analyzed after 1 day of
aggregation.
Magic angle spinning solid-state NMR
spectroscopy
Isotopically labeled samples were prepared and
then packed by pelleting a hydrated suspension of
purified protein aggregates into 3.2 mm zirconia thin
wall MAS rotors (Bruker Biospin, Billerica, MA). This
sedimentation process was done using a home-built
ultracentrifugal packing device under centrifugation at
~130,000g in a Beckman Coulter Optima L-100 XP
ultracentrifuge equipped with a SW-32 Ti rotor [96].
For ΔN15-Q44-HttEx1, 7 mg of protein was packed
into the MAS rotor. Caps were sealed to the rotor with
epoxy glue to ensure stable sample hydration.
Samples were studied byMAS ssNMR in an unfrozen
state. 1D 13C and 2D 13C–13C MAS ssNMR
experiments were performed using a wide-bore
Bruker Avance I NMR spectrometer operating at a
1H Larmor frequency of 600 MHz (14.1 Tesla) and
equipped with a 3.2-mm MAS probe with an HCN
‘EFree’ coil (Bruker Biospin). 2D 15N–13C NCOCX,
2D 15N–13C NCACX and 2D 15N–13C TEDOR
spectra [63,97] were acquired on a Bruker AVANCE
NEO 600 MHz (14.1 T) spectrometer, using a 3.2-
mm EFree HCN MAS Probe from Bruker Biospin.
Immobilized and rigid parts of the fibrils were studied
using 1D 13C and 2D 13C–13C cross polarization
(CP) based experiments at 12.5 kHz MAS. 13C–13C
correlations were obtained from 2D experiments with
a ramped 1H–13C CP step and 8-ms dipolar-assisted
rotational resonance (DARR) 13C–13C mixing [98].
Dipolar-recoupling curves based on 13C–13C 2D
Proton-Driven Spin Diffusion (PDSD) experiments
were acquired with mixing times of 0, 25, 250, and
500 ms. The volumes of 2D peaks were integrated
using the Sparky NMR software package and
normalized to the corresponding peak volume at the
diagonal in the PDSD experiment that employed 0-
ms mixing [2]. Flexible parts of the fibrils were
identified from 1D J-coupling-based 13C spectra
which were acquired using rotor-synchronized refo-
cused insensitive nuclei-enhanced polarization trans-
fer (INEPT) 1H–13C transfers at 8.333 kHz MAS rate.2D spectra showing 13C–13C correlations between
highly mobile carbons were obtained by combining
refocused INEPT 1H–13C transfers with the P913
total through bond correlation spectroscopy (TOBSY)
pulse sequence [99]. For the 13C 1D experiments,
two-pulse phase modulation (TPPM) 1H decoupling
(typically at 83 kHz) was applied during acquisition,
and for all 2D 13C–13C experiments, the same 1H
decoupling was applied during evolution and acqui-
sition [100]. 2D NCACX, NCOCX and TEDOR
spectra were acquired at 13 kHz MAS and 275 K
temperature, using 100 kHz TPPM proton decou-
pling, 3-s recycle delay and 256 scans per datapoint.
For the NCOCX and NCACX experiments, the first
step was a CP-MAS transfer from 1H to 15N with a
70–100% ramp on 1H, using rf fields of approx. 75
(1H) and 50 (15N) kHz, and optimized contact time of
1 ms. After the first CP step, the magnetization was
transferred from 15N to 13C using a 90%–100% ramp
on 13C, and selective transfer was achieved by setting
the carrier frequency to be on-resonancewith either C′
or Cα and with optimized contact time of 5 and 2 ms,
respectively. For all transfer pulses, a two-
dimensional grid search was used to optimize the
power level of the 13C and 15N channels. The
homonuclear 13C mixing via DARR was set to
50 ms for the NCACX and NCOCX experiments. 2D
TEDOR experiments were recorded using a 5 μs 90°
carbon pulse, 2.5 μs 90° proton pulse, 5 μs 90°
nitrogen pulse, and TEDOR block total durations of
0.6, 1.2, 3, 5 and 8 ms. Spectra were acquired with
Bruker Topspin, processed in NMRPipe [101], and
analyzed with the CcpNmr Analysis program version
2.4 developed by the Collaborative Computation
Project for the NMR community (CCPN). The chem-
ical shifts of 13C and 15N were indirectly referenced to
4,4-dimethyl-4-silapentane-1-1 sulfonic acid and liq-
uid ammonia based on external measurements of the
13C signals of adamantane [102]. Experimental
details for eachMASssNMRexperiment are available
in Table S4.
X-ray powder diffraction
Fibrils were pelleted by ultracentrifugation at
100,000g for 4 h (Beckman Coulter Optima MAX
Ultracentrifuge, with TLA 120.2 rotor) and then the
supernatant was removed. The hydrated pellet was
packed into a glass capillary (0.7 mm) using a
spatula and PBS buffer was inserted on both ends
of the capillary by syringe. Capillaries were then
sealed with capillary wax. A Rigaku FR-E generator
(2 kW, spot size 0.07 mm) with a source wavelength
of 1.541780 Å was placed 65 mm from the sample
and diffraction data was collected on a Rigaku
Saturn 944 CCD camera (Tokyo, Japan) operating
at −45 °C. The sample remained at room tempera-
ture during data collection. Diffraction datasets were
analyzed in Structure Studio v. 2.2.3 r1 (Rigaku).
4740Structural model building
A model β-hairpin structure of a Q44-HttEx1
monomer was built in UCSF Chimera version
1.13.1 using partial structural constraints obtained
previously by MAS NMR [2,40]. Hydrogens were
added to the monomer structure using Dock Prep
and charges were assigned using an AMBER
ff14SB force field. The monomer structure was
duplicated and the duplicate was docked to the
original using a Dock Prep method, which considers
both steric interactions and H-bonds, to create a two-
molecule sheet structure. The two-molecule struc-
ture was subsequently iteratively duplicated and
docked using Dock Prep to create an 18-mer
composed of nine two-molecule sheets. Each
structure underwent an iterative energy minimization
process involving a total of 12,000 steepest descent
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HD, Huntington's disease; htt, huntingtin; httNT, huntingtin
N-terminal domain; polyQ, polyglutamine; PRD, proline-
rich domain; HttEx1, huntingtin exon 1; Q44-HttEx1,
huntingtin exon 1 with 44 residues in the polyQ domain;
MBP-Q44-HttEx1, fusion protein of maltose binding
protein and Q44-HttEx1; ΔN15-Q44-HttEx1, Q44-HttEx1
lacking the first 15 residues of the httNT domain; FXa,
Factor Xa; FP:P, fusion protein to protease molar ratio;
MAS ssNMR, magic angle spinning solid state nuclear
magnetic resonance; CP, cross polarization; DARR,
dipolar-assisted rotational resonance; PDSD, proton-
driven spin diffusion; INEPT, insensitive nuclei enhanced
by polarization transfer; TOBSY, through bond correlation
spectroscopy; TPPM, two-pulse phase-modulated de-
coupling; TEM, transmission electron microscopy; ESI-
TOF MS, electrospray ionization time-of-flight mass
spectrometry.References
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